Skip to main content
. 2018 Aug 8;8(8):e021900. doi: 10.1136/bmjopen-2018-021900

Table 4.

Correlations between PROBE and EQ-5D-5L items (convergent validity)

EQ-5D-5L PROBE Correlation 95% CI
Mobility Q.9 Mobility aids 0.42 0.35 to 0.47
Pain and discomfort Q.10 Pain medications 0.55 0.50 to 0.60
Q.11.1 Acute pain (activities) 0.42 0.36 to 0.48
Q.11.2 Acute pain (interference) 0.39 0.32 to 0.45
Q.12.1 Chronic pain (activities) 0.56 0.51 to 0.61
Q.12.2 Chronic pain (interference) 0.57 0.52 to 0.62
Self-care Q.13 Activities of daily living 0.65 0.61 to 0.69
Usual activities Q.13 Activities of daily living 0.71 0.67 to 0.74
Anxiety N/A N/A N/A
Utility index score Total score 0.67 0.62 to 0.71

EQ-5D-5L, EuroQol five dimension 5-level instrument; EQ-VAS, EuroQol visual analogue scale; N/A, not applicable; PROBE, Patient Reported Outcomes, Burdens and Experiences.